Wir verwenden Cookies, um für diese Website Funktionen wie z.B. Login, einen Warenkorb oder die Sprachwahl zu ermöglichen. Weiterhin nutzen wir für anonymisierte, statistische Auswertungen der Nutzung Google Analytics, welches Cookies setzt. Mehr Informationen finden Sie in unserer Datenschutzerklärung.
OK, ich bin einverstanden Ich möchte keine Google Analytics-Cookies
Quintessence International
Login:
Benutzername:

Kennwort:

Plattform:

Kennwort vergessen?

Registrieren

Quintessence Int 37 (2006), Nr. 5     5. Apr. 2006
Quintessence Int 37 (2006), Nr. 5  (05.04.2006)

Seite 391-394, PubMed:16683687, Sprache: Englisch


In vitro antibacterial efficacy of a new chlorhexidine slow-release device
Lin, Shaul / Levin, Liran / Weiss, Ervin Izhak / Peled, Micha / Fuss, Zvi
Objective: The aim of this study was to evaluate and compare the antibacterial effect of chlorhexidine and calcium hydroxide slow-release devices on oral bacteria.
Method and Materials: The agar diffusion test was used to evaluate the antibacterial effect of the slow-release devices Activ Point (chlorhexidine; Roeko) and Calcium Hydroxide Plus Point (Roeko) on 8 anaerobic and 2 facultative oral bacterial strains, as well as 2 bacterial cultures randomly sampled from necrotic root canals and incubated in anaerobic and aerobic broth for 48 hours. The efficiency of the medicaments against the various strains was evaluated using a nonparametric test (Friedman type) and a second nonparametric test (Wilcoxon's signed rank test).
Results: Activ Point produced significantly larger inhibition zones (P < .001) than the calcium hydroxide slow-release device around all tested bacterial strains.
Conclusion: The chlorhexidine slow-release device (Activ Point) exhibited significant antibacterial activity in the agar diffusion test and merits study as an intracanal medicament.

Schlagwörter: agar diffusion test, calcium hydroxide, chlorhexidine, slow-release device
Volltext (keine Berechtigung) einzeln als PDF kaufen (20.00 €)Endnote-Export